Global Cell & Gene Therapy Cold Chain Logistics Market, By Component (Cryogenic Shippers, Cryogenic Storage Freezers, Ultra Low Freezers, Cold Chain Management Systems, Shipment and Storage Medium, Cryogenic Packout Kits, Others), By Services Offered (Transportation, Storage, Packaging) By Mode of Transportation (Air, Ground, Water), By Holding Temperature Range (Cryogenic, Refrigerated, Ambient, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), By Region, Competition, Forecast and Opportunities, 2017-2027

March 2022 | 300 pages | ID: GBDE8BC192A3EN
TechSci Research

Abstracts

Global cell & gene therapy cold chain logistics market valued at USD1316.93 million in the year 2021, that is also anticipated to grow at a CAGR of 14.29% during the forecast period, 2023-2027 to achieve a market value of USD2880.76 million by 2027F. The market growth can be attributed to growing instances of chronic diseases like cancer, cardiovascular diseases, neurological disorders. Increasing geriatric population and their susceptibility toward the chronic diseases are also supporting this growth since the demands for the treatment has increased many folds. Rapidly growing clinical trials and FDA approvals toward authorizing cell and gene therapy is also anticipated to support the growth of the global cell & gene therapy cold chain logistics market in the next five years. Increasing approvals are further supporting the surging demands for the cell & gene therapy products and their transportation to different parts of the world, thereby positively influencing the growth of the global cell & gene therapy cold chain logistics market in the future five years. Increasing number of market players in the industry, and manufacturers of the cell & gene therapy products entering the cold chain logistics market for the storage and preserving cell & gene therapy products in cold chain along with acquiring the existing small players or entering into partnerships & agreements, are expected to facilitate the growth of the global cell & gene therapy cold chain logistics market in the forecast years through 2027.

The global cell & gene therapy cold chain logistics market is segmented by component, services offered, mode of transportation, holding temperature range, end user, regional distribution, and competition landscape. Based on component, the market is further bifurcated into cryogenic shippers, cryogenic storage freezers, ultra-low freezers, cold chain management systems, shipment and storage medium, cryogenic pack-out kits, and others. Cryogenic shippers are anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years on the grounds of increasing demands for the storage and transportation of cells, tissues, and a variety of other biological samples that require extreme cold storage, for storing and transportation thus driving the growth of the global cell & gene therapy cold chain logistics market in the future five years.

AmerisourceBergen Corporation (World Courier), United Parcel Service (Marken), Catalent, Inc., BioLife Solutions, Inc., Cryoport, Inc., Atelerix Ltd., Biostor Ltd., Thermo Fisher Scientific Inc., Life Science Group Ltd (LSG), Yourway Biopharma Services Company, Bertelsmann SE & Co. KGaA (Arvato Supply Chain Solutions), Be The Match Therapeutics, are among the major market players in the global platform that lead the market growth of the global cell & gene therapy cold chain logistics market.

Years considered for this report:

• Historical Years: 2017- 2020
• Base Year: 2021
• Estimated Year: 2022
• Forecast Period: 2023 – 2027

Objective of the Study:

• To analyze the market size of global cell & gene therapy cold chain logistics market from 2017 to 2020.
• To estimate and forecast the market size of global cell & gene therapy cold chain logistics market from 2021 to 2022 and growth rate until 2027.
• To classify and forecast global cell & gene therapy cold chain logistics market based on component, services offered, mode of transportation, holding temperature range, end user, regional distribution, and competition landscape.
• To identify dominant region or segment in the global cell & gene therapy cold chain logistics market.
• To identify drivers and challenges for global cell & gene therapy cold chain logistics market.
• To examine competitive developments such as expansions, new service launches, mergers & acquisitions, etc., in global cell & gene therapy cold chain logistics market.
• To identify and analyze the profile of leading players operating in global cell & gene therapy cold chain logistics market.
• To identify key sustainable strategies adopted by market players in global cell & gene therapy cold chain logistics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the service providers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global cell & gene therapy cold chain logistics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

• Service providers, suppliers
• Distributors and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to cell & gene therapy cold chain logistics
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global cell & gene therapy cold chain logistics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Cell & Gene Therapy Cold Chain Logistics Market, By Component:
• Cryogenic Shippers
• Cryogenic Storage Freezers
• Ultra-Low Freezers
• Cold Chain Management Systems
• Shipment and Storage Medium
• Cryogenic Packout Kits
• Others
• Cell & Gene Therapy Cold Chain Logistics Market, By Services Offered:
• Transportation
• Storage
• Packaging
• Cell & Gene Therapy Cold Chain Logistics Market by Mode of Transportation:
• Air
• Ground
• Water
• Cell & Gene Therapy Cold Chain Logistics Market, By Holding Temperature Range:
• Cryogenic
• Refrigerated
• Ambient
• Others
• Cell & Gene Therapy Cold Chain Logistics Market, By End User:
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others
• Cell & Gene Therapy Cold Chain Logistics Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• France
• United Kingdom
• Spain
• Italy
• Asia-Pacific
• China
• Japan
• South Korea
• Australia
• India
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• Israel
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Cell & Gene Therapy Cold Chain Logistics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. SERVICE OVERVIEW

2. RESEARCH METHODOLOGY

3. IMPACT OF COVID-19 ON GLOBAL CELL & GENE THERAPY COLD CHAIN LOGISTICS MARKET

4. EXECUTIVE SUMMARY

5. VOICE OF CUSTOMER

5.1. Brand Awareness (Aided/Unaided)
5.2. Product Awareness
5.3. Customer Satisfaction Analysis
5.4. Pricing Analysis
5.5. Unmet Needs/Challenges

6. GLOBAL CELL & GENE THERAPY MARKET OVERVIEW

7. GLOBAL CELL & GENE THERAPY COLD CHAIN LOGISTICS MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Component (Cryogenic Shippers, Cryogenic Storage Freezers, Ultra Low Freezers, Cold Chain Management Systems, Shipment and Storage Medium, Cryogenic Packout Kits, Others {Shipment Containers, Reusable Boxes, etc.})
  7.2.2. By Services Offered (Transportation, Storage, Packaging)
  7.2.3. By Mode of Transportation (Air, Ground, Water)
  7.2.4. By Holding Temperature Range (Cryogenic, Refrigerated, Ambient, Others {Deep Freezers, Dry Ice, etc.})
  7.2.5. By End User (Pharmaceutical & BioHolding Temperature Range Companies, Academic & Research Institutes, Others)
  7.2.6. By Company
  7.2.7. By Region
7.3. Product Market Map

8. NORTH AMERICA CELL & GENE THERAPY COLD CHAIN LOGISTICS MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Component
  8.2.2. By Services Offered
  8.2.3. By Mode of Transportation
  8.2.4. By Holding Temperature Range
  8.2.5. By End User
  8.2.6. By Country
8.3. North America: Country Analysis
  8.3.1. United States Cell & Gene Therapy Cold Chain Logistics Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Component
      8.3.1.2.2. By Services Offered
      8.3.1.2.3. By Mode of Transportation
      8.3.1.2.4. By Holding Temperature Range
      8.3.1.2.5. By End User
  8.3.2. Canada Cell & Gene Therapy Cold Chain Logistics Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Component
      8.3.2.2.2. By Services Offered
      8.3.2.2.3. By Mode of Transportation
      8.3.2.2.4. By Holding Temperature Range
      8.3.2.2.5. By End User
  8.3.3. Mexico Cell & Gene Therapy Cold Chain Logistics Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Component
      8.3.3.2.2. By Services Offered
      8.3.3.2.3. By Mode of Transportation
      8.3.3.2.4. By Holding Temperature Range
      8.3.3.2.5. By End User

9. EUROPE CELL & GENE THERAPY COLD CHAIN LOGISTICS MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Component
  9.2.2. By Services Offered
  9.2.3. By Mode of Transportation
  9.2.4. By Holding Temperature Range
  9.2.5. By End User
  9.2.6. By Country
9.3. Europe: Country Analysis
  9.3.1. Germany Cell & Gene Therapy Cold Chain Logistics Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Component
      9.3.1.2.2. By Services Offered
      9.3.1.2.3. By Mode of Transportation
      9.3.1.2.4. By Holding Temperature Range
      9.3.1.2.5. By End User
  9.3.2. France Cell & Gene Therapy Cold Chain Logistics Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Component
      9.3.2.2.2. By Services Offered
      9.3.2.2.3. By Mode of Transportation
      9.3.2.2.4. By Holding Temperature Range
      9.3.2.2.5. By End User
  9.3.3. United Kingdom Cell & Gene Therapy Cold Chain Logistics Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Component
      9.3.3.2.2. By Services Offered
      9.3.3.2.3. By Mode of Transportation
      9.3.3.2.4. By Holding Temperature Range
      9.3.3.2.5. By End User
  9.3.4. Spain Cell & Gene Therapy Cold Chain Logistics Market Outlook
    9.3.4.1. Market Size & Forecast
      9.3.4.1.1. By Value
    9.3.4.2. Market Share & Forecast
      9.3.4.2.1. By Component
      9.3.4.2.2. By Services Offered
      9.3.4.2.3. By Mode of Transportation
      9.3.4.2.4. By Holding Temperature Range
      9.3.4.2.5. By End User
  9.3.5. Italy Cell & Gene Therapy Cold Chain Logistics Market Outlook
    9.3.5.1. Market Size & Forecast
      9.3.5.1.1. By Value
    9.3.5.2. Market Share & Forecast
      9.3.5.2.1. By Component
      9.3.5.2.2. By Services Offered
      9.3.5.2.3. By Mode of Transportation
      9.3.5.2.4. By Holding Temperature Range
      9.3.5.2.5. By End User

10. ASIA-PACIFIC CELL & GENE THERAPY COLD CHAIN LOGISTICS MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Component
  10.2.2. By Services Offered
  10.2.3. By Mode of Transportation
  10.2.4. By Holding Temperature Range
  10.2.5. By End User
  10.2.6. By Country
10.3. Asia-Pacific: Country Analysis
  10.3.1. China Cell & Gene Therapy Cold Chain Logistics Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Component
      10.3.1.2.2. By Services Offered
      10.3.1.2.3. By Mode of Transportation
      10.3.1.2.4. By Holding Temperature Range
      10.3.1.2.5. By End User
  10.3.2. Japan Cell & Gene Therapy Cold Chain Logistics Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Component
      10.3.2.2.2. By Services Offered
      10.3.2.2.3. By Mode of Transportation
      10.3.2.2.4. By Holding Temperature Range
      10.3.2.2.5. By End User
  10.3.3. South Korea Cell & Gene Therapy Cold Chain Logistics Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Component
      10.3.3.2.2. By Services Offered
      10.3.3.2.3. By Mode of Transportation
      10.3.3.2.4. By Holding Temperature Range
      10.3.3.2.5. By End User
  10.3.4. Australia Cell & Gene Therapy Cold Chain Logistics Market Outlook
    10.3.4.1. Market Size & Forecast
      10.3.4.1.1. By Value
    10.3.4.2. Market Share & Forecast
      10.3.4.2.1. By Component
      10.3.4.2.2. By Services Offered
      10.3.4.2.3. By Mode of Transportation
      10.3.4.2.4. By Holding Temperature Range
      10.3.4.2.5. By End User
  10.3.5. India Cell & Gene Therapy Cold Chain Logistics Market Outlook
    10.3.5.1. Market Size & Forecast
      10.3.5.1.1. By Value
    10.3.5.2. Market Share & Forecast
      10.3.5.2.1. By Component
      10.3.5.2.2. By Services Offered
      10.3.5.2.3. By Mode of Transportation
      10.3.5.2.4. By Holding Temperature Range
      10.3.5.2.5. By End User

11. SOUTH AMERICA CELL & GENE THERAPY COLD CHAIN LOGISTICS MARKET OUTLOOK

11.1. Market Size & Forecast
  11.1.1. By Value
11.2. Market Share & Forecast
  11.2.1. By Component
  11.2.2. By Services Offered
  11.2.3. By Mode of Transportation
  11.2.4. By Holding Temperature Range
  11.2.5. By End User
  11.2.6. By Country
11.3. South America: Country Analysis
  11.3.1. Brazil Cell & Gene Therapy Cold Chain Logistics Market Outlook
    11.3.1.1. Market Size & Forecast
      11.3.1.1.1. By Value
    11.3.1.2. Market Share & Forecast
      11.3.1.2.1. By Component
      11.3.1.2.2. By Services Offered
      11.3.1.2.3. By Mode of Transportation
      11.3.1.2.4. By Holding Temperature Range
      11.3.1.2.5. By End User
  11.3.2. Argentina Cell & Gene Therapy Cold Chain Logistics Market Outlook
    11.3.2.1. Market Size & Forecast
      11.3.2.1.1. By Value
    11.3.2.2. Market Share & Forecast
      11.3.2.2.1. By Component
      11.3.2.2.2. By Services Offered
      11.3.2.2.3. By Mode of Transportation
      11.3.2.2.4. By Holding Temperature Range
      11.3.2.2.5. By End User
  11.3.3. Colombia Cell & Gene Therapy Cold Chain Logistics Market Outlook
    11.3.3.1. Market Size & Forecast
      11.3.3.1.1. By Value
    11.3.3.2. Market Share & Forecast
      11.3.3.2.1. By Component
      11.3.3.2.2. By Services Offered
      11.3.3.2.3. By Mode of Transportation
      11.3.3.2.4. By Holding Temperature Range
      11.3.3.2.5. By End User

12. MIDDLE EAST AND AFRICA CELL & GENE THERAPY COLD CHAIN LOGISTICS MARKET OUTLOOK

12.1. Market Size & Forecast
  12.1.1. By Value
12.2. Market Share & Forecast
  12.2.1. By Component
  12.2.2. By Services Offered
  12.2.3. By Mode of Transportation
  12.2.4. By Holding Temperature Range
  12.2.5. By End User
  12.2.6. By Country
12.3. MEA: Country Analysis
  12.3.1. Israel Cell & Gene Therapy Cold Chain Logistics Market Outlook
    12.3.1.1. Market Size & Forecast
      12.3.1.1.1. By Value
    12.3.1.2. Market Share & Forecast
      12.3.1.2.1. By Component
      12.3.1.2.2. By Services Offered
      12.3.1.2.3. By Mode of Transportation
      12.3.1.2.4. By Holding Temperature Range
      12.3.1.2.5. By End User
  12.3.2. UAE Cell & Gene Therapy Cold Chain Logistics Market Outlook
    12.3.2.1. Market Size & Forecast
      12.3.2.1.1. By Value
    12.3.2.2. Market Share & Forecast
      12.3.2.2.1. By Component
      12.3.2.2.2. By Services Offered
      12.3.2.2.3. By Mode of Transportation
      12.3.2.2.4. By Holding Temperature Range
      12.3.2.2.5. By End User
  12.3.3. South Africa Cell & Gene Therapy Cold Chain Logistics Market Outlook
    12.3.3.1. Market Size & Forecast
      12.3.3.1.1. By Value
    12.3.3.2. Market Share & Forecast
      12.3.3.2.1. By Component
      12.3.3.2.2. By Services Offered
      12.3.3.2.3. By Mode of Transportation
      12.3.3.2.4. By Holding Temperature Range
      12.3.3.2.5. By End User
  12.3.4. Saudi Arabia Cell & Gene Therapy Cold Chain Logistics Market Outlook
    12.3.4.1. Market Size & Forecast
      12.3.4.1.1. By Value
    12.3.4.2. Market Share & Forecast
      12.3.4.2.1. By Component
      12.3.4.2.2. By Services Offered
      12.3.4.2.3. By Mode of Transportation
      12.3.4.2.4. By Holding Temperature Range
      12.3.4.2.5. By End User
  12.3.5. UAE Cell & Gene Therapy Cold Chain Logistics Market Outlook
    12.3.5.1. Market Size & Forecast
      12.3.5.1.1. By Value
    12.3.5.2. Market Share & Forecast
      12.3.5.2.1. By Component
      12.3.5.2.2. By Services Offered
      12.3.5.2.3. By Mode of Transportation
      12.3.5.2.4. By Holding Temperature Range
      12.3.5.2.5. By End User

13. MARKET DYNAMICS

13.1. Drivers
13.2. Challenges

14. PATENT ANALYSIS

15. MARKET TRENDS & DEVELOPMENTS

16. COMPETITIVE LANDSCAPE

16.1. AmerisourceBergen Corporation (World Courier)
16.2. United Parcel Service (Marken)
16.3. Catalent, Inc.
16.4. BioLife Solutions, Inc.
16.5. Cryoport, Inc.
16.6. Atelerix Ltd.
16.7. Biostor Ltd.
16.8. Thermo Fisher Scientific Inc.
16.9. Life Science Group Ltd (LSG)
16.10. Yourway Biopharma Services Company
16.11. Bertelsmann SE & Co. KGaA (Arvato Supply Chain Solutions)
16.12. Be The Match Therapeutics

17. STRATEGIC RECOMMENDATIONS

List Of Figures

LIST OF FIGURES

Figure 1: Global Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 2: Global Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 3: Global Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 4: Global Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 5: Global Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 6: Global Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 7: Global Cell & Gene Therapy Cold Chain Logistics Market Share, By Region, By Value, 2017-2027F
Figure 8: Global Cell & Gene Therapy Cold Chain Logistics Market Share, By Company, By Value, 2021
Figure 9: Global Cell & Gene Therapy Cold Chain Logistics Market Map, By Component, Market Size (USD Million) & Growth Rate (%), 2021
Figure 10: Global Cell & Gene Therapy Cold Chain Logistics Market Map, By Services Offered, Market Size (USD Million) & Growth Rate (%), 2021
Figure 11: Global Cell & Gene Therapy Cold Chain Logistics Market Map, By Mode of Transportation, Market Size (USD Million) & Growth Rate (%), 2021
Figure 12: Global Cell & Gene Therapy Cold Chain Logistics Market Map, By Holding Temperature Range, Market Size (USD Million) & Growth Rate (%), 2021
Figure 13: Global Cell & Gene Therapy Cold Chain Logistics Market Map, By End User, Market Size (USD Million) & Growth Rate (%), 2021
Figure 14: Global Cell & Gene Therapy Cold Chain Logistics Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
Figure 15: North America Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 16: North America Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 17: North America Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 18: North America Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 19: North America Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 20: North America Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 21: North America Cell & Gene Therapy Cold Chain Logistics Market Share, By Country, By Value, 2017-2027F
Figure 22: United States Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 23: United States Number of Cell Therapy Clinical Trials Studies, 2018-2021
Figure 24: United States Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 25: United States Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 26: United States Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 27: United States Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 28: United States Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 29: Canada Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 30: Canada Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 31: Canada Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 32: Canada Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 33: Canada Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 34: Canada Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 35: Mexico Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 36: Number of Registered Clinical Studies in Mexico As of February 2021, By Status
Figure 37: Mexico Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 38: Mexico Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 39: Mexico Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 40: Mexico Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 41: Mexico Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 42: Europe Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 43: Europe Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 44: Europe Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 45: Europe Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 46: Europe Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 47: Europe Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 48: Europe Cell & Gene Therapy Cold Chain Logistics Market Share, By Country, By Value, 2017-2027F
Figure 49: Germany Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 50: Percentage of New Cancer Cases in Germany, Both Sexes, All Ages, 2020
Figure 51: Germany Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 52: Germany Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 53: Germany Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 54: Germany Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 55: Germany Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 56: France Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 57: Percentage of New Cancer Cases in France, Both Sexes, All Ages, 2020
Figure 58: France Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 59: France Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 60: France Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 61: France Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 62: France Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 63: United Kingdom Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 64: United Kingdom Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 65: United Kingdom Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 66: United Kingdom Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 67: United Kingdom Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 68: United Kingdom Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 69: Spain Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 70: Percentage of New Cancer Cases in Spain, Both Sexes, All Ages, 2020
Figure 71: Spain Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 72: Spain Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 73: Spain Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 74: Spain Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 75: Spain Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 76: Italy Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 77: Percentage of New Cancer Cases in Italy, Both Sexes, All Ages, 2020
Figure 78: Italy Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 79: Italy Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 80: Italy Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 81: Italy Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 82: Italy Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 83: Asia Pacific Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 84: Asia Pacific Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 85: Asia Pacific Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 86: Asia Pacific Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 87: Asia Pacific Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 88: Asia Pacific Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 89: Asia Pacific Cell & Gene Therapy Cold Chain Logistics Market Share, By Country, By Value, 2017-2027F
Figure 90: China Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 91: China Number of Cell Therapy Clinical Trials Studies, 2018-2021
Figure 92: China Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 93: China Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 94: China Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 95: China Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 96: China Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 97: Japan Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 98: Japan Number of Cell Therapy Clinical Trials Studies, 2018-2021
Figure 99: Japan Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 100: Japan Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 101: Japan Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 102: Japan Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 103: Japan Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 104: South Korea Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 105: Percentage of New Cancer Cases in South Korea, Both Sexes, All Ages, 2020
Figure 106: South Korea Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 107: South Korea Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 108: South Korea Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 109: South Korea Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 110: South Korea Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 111: Australia Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 112: Australia Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 113: Australia Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 114: Australia Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 115: Australia Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 116: Australia Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 117: India Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 118: India Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 119: India Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 120: India Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 121: India Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 122: India Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 123: South America Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 124: South America Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 125: South America Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 126: South America Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 127: South America Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 128: South America Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 129: South America Cell & Gene Therapy Cold Chain Logistics Market Share, By Country, By Value, 2017-2027F
Figure 130: Brazil Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million), 2017-2027F
Figure 131: Brazil Cell & Gene Therapy Cold Chain Logistics Market Share, By Component, By Value, 2017-2027F
Figure 132: Brazil Cell & Gene Therapy Cold Chain Logistics Market Share, By Services Offered, By Value, 2017-2027F
Figure 133: Brazil Cell & Gene Therapy Cold Chain Logistics Market Share, By Mode of Transportation, By Value, 2017-2027F
Figure 134: Brazil Cell & Gene Therapy Cold Chain Logistics Market Share, By Holding Temperature Range, By Value, 2017-2027F
Figure 135: Brazil Cell & Gene Therapy Cold Chain Logistics Market Share, By End User, By Value, 2017-2027F
Figure 136: Argentina Cell & Gene Therapy Cold Chain Logistics Market Size, By Value (USD Million)